Summary of Significant Accounting Policies (Details) - Schedule of expenses related share-based payment arrangements - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Jul. 31, 2022 |
Jul. 31, 2021 |
Jul. 31, 2020 |
|
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Share Based Compensation | $ 1,496 | $ 907 | $ 933 |
Cost of clinical laboratory services [Member] | |||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Share Based Compensation | 14 | 93 | 46 |
Selling, general and administrative [Member] | |||
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Share Based Compensation | $ 1,482 | $ 814 | $ 887 |
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|